Siddharth Patel, MD
Vascular Surgery · Atlanta, GANPI 1821001066
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Silk Road Medical, Inc. accounts for 80.7% of it on its own, with 35 other manufacturers making up the rest. Among vascular surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 636 payments — averaging $476.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$245K
- Boston Scientific$31K
- Medtronic$14K
- Shockwave Medical, Inc$3K
- Bolton Medical Inc$3K
- Inari Medical, Inc.$3K
- plus $5K from 30 others
Across 28 payments — averaging $2770.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$35K
- Bolton Medical Inc$26K
- Medtronic$11K
- Boston Scientific$5K
What the payments were for
- Consulting fees$162,01853%
- Speaking & faculty fees$58,87519%
- Travel & lodging$59,47720%
- Food & beverage$22,6567%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 343 | $244,606 |
| Boston Scientific | 45 | $31,193 |
| Medtronic(2 entities) | 57 | $13,795 |
| Shockwave Medical, Inc | 55 | $3,324 |
| Bolton Medical Inc | 14 | $2,863 |
| Inari Medical, Inc. | 9 | $2,627 |
| Angiodynamics, Inc. | 14 | $632 |
| W. L. Gore & Associates, Inc. | 8 | $592 |
| Abbott | 6 | $427 |
| Johnson & Johnson(2 entities) | 21 | $392 |
| Cvrx, Inc. | 6 | $373 |
| Cook Medical LLC | 5 | $283 |
| Avinger Inc. | 3 | $252 |
| Organogenesis Inc. | 2 | $199 |
| Aroa Biosurgery Incorporated | 2 | $197 |
| Penumbra, Inc. | 3 | $158 |
| Philips North America LLC | 3 | $146 |
| Alkermes, Inc. | 1 | $120 |
| Pfizer | 7 | $107 |
| Truvic Medical, Inc. | 4 | $97 |
| Imperative Care, Inc | 3 | $79 |
| Lemaitre Vascular, Inc. | 4 | $75 |
| Bard Peripheral Vascular, Inc. | 4 | $71 |
| Reflow Medical Inc | 2 | $57 |
| Siemens Medical Solutions USA, Inc. | 2 | $52 |
| Humacyte Global, Inc. | 1 | $51 |
| Endologix LLC | 1 | $42 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Inspiremd Ltd | 1 | $38 |
| Vertex | 1 | $31 |
| Cordis US CORP. | 1 | $27 |
| Terumo Medical Corporation | 1 | $22 |
| Acera Surgical, Inc. | 1 | $19 |
| Artivion, Inc. | 1 | $15 |
| AbbVie | 1 | $13 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$315,098
- ENROUTE Transcarotid Stent$167,359
- ENHANCE Transcarotid Peripheral Access Kit$108,511
- ENROUTE Transcarotid Stent System$71,279
- ENROUTE 0.014 Guidewire$71,279
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$50,155
- ENROUTE .014 Guidewire$37,232
- IN.PACT Admiral$11,182
- FLOWTRIEVER CATHETER, S$2,973
- CT THROMBECTOMY SYSTEM KIT$2,282
- Relay Plus$2,122
- GENERAL VASCULAR INTERVENTION$2,023
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,824
- CAROTID WALLSTENT$1,250
- ENDURANT IIS$931
- GENERAL - THERAPIES$654
- ARISTADA$480
- Relay Grafts$405
- Barostim Neo System$278
- DRAGONFLY OPSTAR$187
How this compares
$303,026 in reported general payments places this provider in the 95th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 45 | $27,541 |
| ClopidogrelClopidogrel Bisulfate | 83 | $308 |
| Tramadol Hcl | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $392 | $27,54145 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Atlanta
- Walaya Methodius-RayfordAtlanta$79K
- Andrew UnzeitigAtlanta$46K
- Yazan DuwayriAtlanta$44K
- Anumeha WhisenhuntAtlanta$33K
- James ChangAtlanta$31K
- Chad AlemanAtlanta$21K
- Olamide AlabiAtlanta$19K
- Jorge CorsoAtlanta$18K
- Peter H DoublerAtlanta$15K
- Eyal Ben-ArieAtlanta$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.